167 related articles for article (PubMed ID: 34735755)
1. Topical Tacrolimus 0.1% for treatment of cutaneous microcystic lymphatic malformations.
Salvia SA; Amore MA; Papendieck CM
Lymphology; 2021; 54(2):106-111. PubMed ID: 34735755
[TBL] [Abstract][Full Text] [Related]
2. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
Leducq S; Caille A; Barbarot S; Bénéton N; Bessis D; Boccara O; Bursztejn AC; Chiaverini C; Dompmartin A; Droitcourt C; Gissot V; Goga D; Guibaud L; Herbreteau D; Le Touze A; Léauté-Labrèze C; Lorette G; Mallet S; Martin L; Mazereeuw-Hautier J; Phan A; Plantin P; Quéré I; Vabres P; Bourgoin H; Giraudeau B; Maruani A;
Trials; 2019 Dec; 20(1):739. PubMed ID: 31847908
[TBL] [Abstract][Full Text] [Related]
3. Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.
Marchand A; Caille A; Gissot V; Giraudeau B; Lengelle C; Bourgoin H; Largeau B; Leducq S; Maruani A
Trials; 2022 Jul; 23(1):557. PubMed ID: 35804404
[TBL] [Abstract][Full Text] [Related]
4. Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians.
Gallagher JR; Martini J; Carroll S; Small A; Teng J
Orphanet J Rare Dis; 2022 May; 17(1):192. PubMed ID: 35550604
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil for microcystic lymphatic malformations of the head and neck: A prospective study.
Koshy JC; Eisemann BS; Agrawal N; Pimpalwar S; Edmonds JL
Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):980-2. PubMed ID: 25921076
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective analysis of classification and treatment of microcystic lymphatic malformations of tongue].
Li KL; Wang YP; Chen T; Tai MZ; Ge CX; Qin ZP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 May; 54(5):303-308. PubMed ID: 31091562
[No Abstract] [Full Text] [Related]
7. Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations.
Ivars M; Redondo P
JAMA Dermatol; 2017 Jan; 153(1):103-105. PubMed ID: 27784048
[No Abstract] [Full Text] [Related]
8. Low power radiofrequency ablation for symptomatic microcystic lymphatic malformation of the tongue.
Ryu NG; Park SK; Jeong HS
Int J Pediatr Otorhinolaryngol; 2008 Nov; 72(11):1731-4. PubMed ID: 18819717
[TBL] [Abstract][Full Text] [Related]
9. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations.
Danial C; Tichy AL; Tariq U; Swetman GL; Khuu P; Leung TH; Benjamin L; Teng J; Vasanawala SS; Lane AT
J Am Acad Dermatol; 2014 Jun; 70(6):1050-7. PubMed ID: 24656411
[TBL] [Abstract][Full Text] [Related]
10. Current status, pitfalls and future directions in the diagnosis and therapy of lymphatic malformation.
Sun RW; Tuchin VV; Zharov VP; Galanzha EI; Richter GT
J Biophotonics; 2018 Aug; 11(8):e201700124. PubMed ID: 28851128
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic malformations: diagnosis and management.
Elluru RG; Balakrishnan K; Padua HM
Semin Pediatr Surg; 2014 Aug; 23(4):178-85. PubMed ID: 25241095
[TBL] [Abstract][Full Text] [Related]
12. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
Badia P; Ricci K; Gurria JP; Dasgupta R; Patel M; Hammill A
Pediatr Blood Cancer; 2020 Apr; 67(4):e28088. PubMed ID: 31930696
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus in the Treatment of Microcystic Lymphatic Malformations: A Systematic Review.
Teng JMC; Hammill A; Martini J; Treat J
Lymphat Res Biol; 2023 Apr; 21(2):101-110. PubMed ID: 35852876
[No Abstract] [Full Text] [Related]
14. Use of topical rapamycin in the treatment of superficial lymphatic malformations.
García-Montero P; Del Boz J; Baselga-Torres E; Azaña-Defez JM; Alcaraz-Vera M; Tercedor-Sánchez J; Noguera-Morel L; Vera-Casaño Á
J Am Acad Dermatol; 2019 Feb; 80(2):508-515. PubMed ID: 30296533
[TBL] [Abstract][Full Text] [Related]
15. [Management of lymphatic malformations in oral and maxillofacial regions: the rationale according to the new classification].
Zheng JW; Qin ZP; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):553-6. PubMed ID: 16400476
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
[TBL] [Abstract][Full Text] [Related]
17. Topical rapamycin and microcystic lymphatic malformations.
Gu Y; Sebaratnam DF
J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
[No Abstract] [Full Text] [Related]
18. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.
Peters DA; Courtemanche DJ; Heran MKS; Ludemann JP; Prendiville JS
Plast Reconstr Surg; 2006 Nov; 118(6):1441-1446. PubMed ID: 17051116
[TBL] [Abstract][Full Text] [Related]
19. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
20. French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformations.
Leboulanger N; Bisdorff A; Boccara O; Dompmartin A; Guibaud L; Labreze C; Lagier J; Lebrun-Vignes B; Herbreteau D; Joly A; Malloizel-Delaunay J; Martel A; Munck S; Saint-Aubin F; Maruani A
Orphanet J Rare Dis; 2023 Jan; 18(1):10. PubMed ID: 36639640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
